Can GHB Cause Seizures?

Yes, and the ones that kill people happen during withdrawal, not while someone is high. If you use GHB or GBL heavily and around the clock, stopping suddenly can trigger seizures within hours, because your brain has adapted to constant sedation and rebounds into over-excitation with nothing holding it back.

A heavy overdose can also produce seizure-like jerking as someone loses consciousness. That is a different thing with a different mechanism, and both are emergencies.

Withdrawal seizures are the main danger

GHB works mainly as a GABA-B receptor agonist, boosting the brain’s primary inhibitory system. Dose every few hours, day and night, for weeks, and the brain compensates by downregulating that inhibitory system to stay level against the constant sedation.

Take the GHB away and the compensation stands alone. Too little inhibition, far too much excitation, a state of central nervous system hyperexcitability. Seizures are one of the worst outcomes of it.

A case series of seven consecutive patients with GHB withdrawal syndrome, published in Annals of Emergency Medicine in 2001, documented onset 1 to 6 hours after the last dose and a course running 5 to 15 days, with seizures and delirium among the complications. A 2004 review in Drug and Alcohol Dependence describes withdrawal that does not respond fully to standard treatment, with benzodiazepine-refractory cases requiring other sedatives, mainly pentobarbital or chloral hydrate.

Two things make this worse than most withdrawal syndromes.

It is fast. GHB’s half-life is roughly 30 to 60 minutes, so withdrawal can begin 1 to 6 hours after the last dose, and seizures cluster in the first 24 to 48 hours. There is no comfortable window in which to reconsider.

It catches people who did not choose to stop. The risk belongs to daily, around-the-clock users, not weekend users, and the pattern that builds dependence is redosing every 2 to 4 hours to hold the effect. Losing supply unexpectedly, or being admitted to hospital for something unrelated, starts withdrawal with no warning and no plan.

Do not detox from heavy GHB or GBL use at home. The timeline and why hospital treatment is required is in our GHB withdrawal guide.

The jerking during an overdose is something else

At the opposite end, as a large dose pushes someone toward unconsciousness, myoclonic jerking, twitching, and tonic-clonic-like movements of the limbs or face are common, often arriving right as they go under. A 2016 Swiss emergency department series on acute GHB toxicity found reduced consciousness and these motor signs among the frequent presentations.

The clinical nuance is that these movements often are not true epileptic seizures, and they frequently resolve on their own as the drug wears off, sometimes with the person waking abruptly. You cannot tell the difference while it is happening, and it does not change what you do. The jerking marks a dangerous overdose, and GHB overdose also suppresses breathing.

Risk climbs sharply when GHB is combined with another depressant. Alcohol is the worst of them, because both suppress the same systems and the overdose threshold drops out from under you. See GHB and alcohol.

Why GHB touches seizure circuitry at all

There is a pharmacological reason these two things are connected. At high doses GHB acts on GABA-B receptors in thalamocortical circuits, the same networks involved in generalized absence seizures. GHB is reliable enough at producing absence-type EEG activity that it is used as a laboratory model of absence seizures.

A 2015 critical evaluation in CNS Neuroscience and Therapeutics concluded that GHB produces events that can confidently be classified as absence seizures, though that is established mainly in rats.

This is animal-model evidence and does not translate directly to human recreational doses. What it explains is the mechanism. GHB is not an inert sedative. It engages circuitry capable of generating seizure activity, which is part of why both ends of the dose range can tip over.

What raises the risk

• Daily, high-frequency dosing. The single biggest factor. Dependence can develop within weeks of around-the-clock use.
• Stopping abruptly, whether by choice or because supply vanished.
• Mixing with other depressants. Alcohol, benzodiazepines and opioids deepen overdose and raise the chance of seizure-like collapse.
• GBL specifically. It converts to GHB and causes the same dependence, but it is more concentrated by volume, so overdose is easier to reach. See GHB vs GBL.
• A personal history of epilepsy or a low seizure threshold, in both intoxication and withdrawal.

If someone seizes

Withdrawal seizure or overdose jerking, the response is identical.

1. Call emergency services. Do not wait to see whether it passes.
2. Do not restrain them, and put nothing in their mouth.
3. Clear hard objects away and cushion their head.
4. Time it. More than 5 minutes, repeated seizures, or failure to regain consciousness is a dire emergency.
5. Once the jerking stops, roll them onto their side to protect the airway, and watch their breathing. GHB suppresses breathing as well.
6. Tell paramedics GHB or GBL is involved, and name any alcohol or other drugs. This changes treatment directly, especially if withdrawal is the cause.

Many jurisdictions have Good Samaritan laws protecting people who call for help at a drug-related emergency. Call regardless.

Neither of these is something to ride out at home. If you use GHB or GBL daily, the one thing not to do is stop abruptly without medical support, and that is worth arranging before you are forced into it.

For dosing, effects and overdose signs, see our GHB harm reduction guide. For the full withdrawal picture, see GHB withdrawal. Before combining GHB with anything, check the interaction checker.

Sources

• Gamma-hydroxybutyrate withdrawal syndrome. Annals of Emergency Medicine, 2001. PMID 11174231
• Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug and Alcohol Dependence, 2004. PMID 15225884
• Presentations to an urban emergency department in Switzerland due to acute gamma-hydroxybutyrate toxicity. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 2016. PMID 27581664
• A critical evaluation of the gamma-hydroxybutyrate (GHB) model of absence seizures. CNS Neuroscience and Therapeutics, 2015. PMID 25403866